PNN
Positive News Network
three lenses on every headline
← back to feed
FTFinancial Times·2d
score-0.40

FDA Declines China's Ivonescimab, Testing U.S. Scrutiny of Biotech

“The phrase "blow to" and rejection framing convey negative business implications without invoking fear or catastrophe.”

0
0 💬
read original ↗

Help us calibrate

Two quick questions. 0 responses so far.

Was the AI score accurate?
Did you like the reframe?

0 comments

0/2000 · 1 comment per minute

No comments yet. Be the first.